137 related articles for article (PubMed ID: 12693711)
21. Different Efflux Transporter Affinity and Metabolism of
Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
[TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
23. Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
Nucl Med Commun; 1997 Mar; 18(3):235-40. PubMed ID: 9106777
[TBL] [Abstract][Full Text] [Related]
24. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake.
Perek N; Le Jeune N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Aug; 20(4):391-400. PubMed ID: 16114987
[TBL] [Abstract][Full Text] [Related]
25. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
26. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
27. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
29. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
[TBL] [Abstract][Full Text] [Related]
30. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
[TBL] [Abstract][Full Text] [Related]
31. MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy.
Ak Y; Demirel G; Gülbas Z
Nucl Med Commun; 2007 Jul; 28(7):541-6. PubMed ID: 17538395
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
Bergmann R; Brust P; Scheunemann M; Pietzsch HJ; Seifert S; Roux F; Johannsen B
Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
[TBL] [Abstract][Full Text] [Related]
34. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Söderlund V; Jonsson C; Bauer HC; Brosjö O; Jacobsson H
J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
[TBL] [Abstract][Full Text] [Related]
35. Investigation of brain tumours with (99m)Tc-MIBI SPET.
Baldari S; Restifo Pecorella G; Cosentino S; Minutoli F
Q J Nucl Med; 2002 Dec; 46(4):336-45. PubMed ID: 12411875
[TBL] [Abstract][Full Text] [Related]
36. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
[TBL] [Abstract][Full Text] [Related]
37. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi.
Ding HJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Appl Radiat Isot; 2002 Jun; 56(6):853-6. PubMed ID: 12102342
[TBL] [Abstract][Full Text] [Related]
38. Monitoring mitochondrial metabolisms in irradiated human cancer cells with (99m)Tc-MIBI.
Furuta M; Nozaki M; Kawashima M; Iimuro M; Okayama A; Fukushima M; Natsui S; Souma R; Jinnai M
Cancer Lett; 2004 Aug; 212(1):105-11. PubMed ID: 15246566
[TBL] [Abstract][Full Text] [Related]
39. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the uptake and clearance of Tc-99m MIBI, Tl-201 and Ga-67 in drug-resistant lymphoma cell lines.
Tsai SC; Shiau YC; Wang JJ; Ho YJ; Kao CH
Cancer Lett; 2001 Oct; 171(2):147-52. PubMed ID: 11520598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]